Fda
Federal · 1-10 Employees
View Company Info for Free
Overview
Website
www.fda483resourcecenter.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Fda
A resource for US Food and Drug Administration (FDA) enforcement actions (Form 483, Facility Inspection, Warning Letter, Import)Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Fda your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Fda launches new products
Fda, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Fda recently announced quarterly report
Check out if Fda is spiking on competitors!
Check if Fda has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Fda
Funding: Get notified immidiatlly once Fda has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Fda had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Fda is experiencing very low activity levels compared to other companies in the Government sector.
What does this means?
Fda is drawing exceptional interest within the Government industry, suggesting notable developments or strong market momentum, learn more about Fda.
Fda News & Media
Do not use certain pregnancy, ovulation, UTI tests, FDA warns - KSL NewsRadio
Consumers shouldn’t use certain tests manufactured by Universal Meditech Inc., the US Food and Drug Administration warned Friday.FDA approves first oral postpartum depression pill
Biogen and Sage Therapeutics' collaboration to develop Zurzuvae has proved fruitful. The FDA approved the oral pill specifically for the treatment of postpartum depression (PPD), making it the first of its kind in a class of antidepressants intended specifically for new mothers. According to research by the CDC, one in eight women will experience symptoms of postpartum depression. Symptoms of PPD can occur quite intensely after birth and can be dangerous because it can interfereFirst-ever postpartum depression pill, Zurzuvae, approved by FDA
Of the 196 patients who completed the 45-day clinical trial, women who took zuranolone saw “statistically significant improvements” by day 15.Thousands of birth control pills recalled, may be ineffective, FDA warns
Testing revealed some lots of the Tydemy birth control tablets did not have enough of a key ingredient.
Read more news
Top Federal Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Fda
Sign Up For FreeTo access detailed company insights
A resource for US Food and Drug Administration (FDA) enforcement actions (Form 483, Facility Inspection, Warning Letter, Import)... Read More
